Revenue Comparison
Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Pfizer 15.034, Roche 17.1305.
* Roche reports semi-annually. Values are evenly split across both quarters within each half.
Pfizer vs Roche Net Worth and Market Cap
Pfizer (PFE) and Roche (RHHBY) are peers in GLP-1. Pfizer reported revenue of $15.0B as of Q2 2026, compared with $34.3B for Roche. Roche leads on revenue.
Pfizer's gross margin is 72.8% versus 71.7% for Roche. Pfizer's net margin is -1.6% versus 17.9% for Roche.
Key differences
- Revenue growth on the same quarter a year earlier: Pfizer +2.6% (Q2 2026), Roche -4.2% (Q4 2025).
- Pfizer keeps more of its revenue as operating profit: a 31.3% operating margin, against 23.2% at Roche.
- Pfizer's KPIs on Sterling include Abrysvo Revenues by Region (Quarterly) and Comirnaty Revenues by Region (Quarterly).
- Roche's KPIs on Sterling include Carmot Asset Pipeline: CT-388, CT-996, CT-868 Trial Readout Timeline and CT-868 (Acmopatide) Discontinuation.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Pfizer, Roche.| Metric | Pfizer | Roche |
|---|---|---|
| Market Cap | - | - |
| Revenue | $15.03B | $34.26B |
| Cost of Revenue | $4.09B | $9.68B |
| Gross Profit | $10.94B | $24.58B |
| Operating Income | $4.71B | $7.96B |
| Net Income | $-246.00M | $6.13B |
| R&D Expense | $2.81B | $7.48B |
| Earnings Per Share | -$0.04 | $0.95 |
| Gross Margin | 72.8% | 71.7% |
| Operating Margin | 31.3% | 23.2% |
| Net Profit Margin | -1.6% | 17.9% |
| Free Cash Flow | $302.00M | $10.67B |
| Cumulative Free Cash Flow | $356.70B | $299.34B |
| Operating Cash Flow | $835.00M | $13.12B |
| Cash & Equivalents | $976.00M | $6.32B |